Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials

PURPOSE: Results from previous randomised controlled trials (RCTs) investigating whether the addition of bevacizumab to neoadjuvant chemotherapy (NAC) could statistically significantly increase the pathological complete response (pCR) and to identify which subgroup would benefit most from such regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Li, Yao, Guang-yu, Liu, Min-feng, Chen, Lu-jia, Hu, Xiao-lei, Ye, Chang-sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699216/
https://www.ncbi.nlm.nih.gov/pubmed/26717149
http://dx.doi.org/10.1371/journal.pone.0145442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699216/
https://www.ncbi.nlm.nih.gov/pubmed/26717149
http://dx.doi.org/10.1371/journal.pone.0145442

Ejemplares similares